Mechanism of action of Type 2 Sodium-Glucose Cotransporter Inhibitors: Beyond glycaemic control

Type 2 Sodium-Glucose Cotransporter (SGLT2) Inhibitors exercise their glucose-lowering effect through the inhibition of glucose reabsorption in the kidney. However, the cardiovascular and renal effects, as well as in those of cardiac failure, seem to occur independently from the glucose–lowering eff...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2020

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23005

Acceso en línea:

https://doi.org/10.1016/j.rccar.2019.12.003
https://repository.urosario.edu.co/handle/10336/23005

Palabra clave:

Albumin
Sodium glucose cotransporter inhibitor
Uric acid
Adipose tissue
Antidiarrheal activity
Antihypertensive activity
Article
Cardiac muscle cell
Cell metabolism
Drug mechanism
Human
Uric acid urine level
Diabetes
Heart failure
Treatment

Rights

License

Abierto (Texto Completo)